Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELVN | RLAY | BCRX | ||
| Company | Enliven Therapeutics Inc | Relay Therapeutics Inc | Biocryst Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 51.52 | 18.89 | 9.78 | ||
| High | 53.24 | 19.73 | 9.91 | ||
| Low | 50.89 | 18.41 | 9.17 | ||
| Latest | 53.16 | 19.51 | 9.41 | ||
| Change | +1.43 | +0.43 | -0.33 | ||
| % Change | +2.76% | +2.25% | -3.39% | ||
| Volume | 500,700 | 1,538,000 | 6,813,700 | ||
| 20-Day Average Volume | 1,860,220 | 4,624,530 | 6,768,270 | ||
| Previous Close | 51.73 | 19.08 | 9.74 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 49.25 | 18.34 | 9.83 | ||
| 20-Day Raw Stochastic | 99.35% | 78.72% | 25.36% | ||
| 20-Day Relative Strength | 65.63 | 61.49 | 49.09 | ||
| Weighted Alpha | +62.18 | +403.38 | +16.28 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.65% since 07/08/26 | -0.61% since 07/08/26 | -15.30% since 07/08/26 | ||
| Low | 49.51 on 07/10/26 | 18.33 on 07/13/26 | 9.17 on 07/15/26 | ||
| High | 53.24 on 07/15/26 | 20.79 on 07/09/26 | 11.22 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +25.50% since 06/15/26 | +30.41% since 06/15/26 | +3.86% since 06/15/26 | ||
| Low | 40.95 on 06/16/26 | 14.77 on 06/16/26 | 8.80 on 06/16/26 | ||
| High | 53.24 on 07/15/26 | 20.79 on 07/09/26 | 11.22 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +20.96% since 04/15/26 | +25.95% since 04/15/26 | -0.32% since 04/15/26 | ||
| Low | 33.45 on 06/08/26 | 11.62 on 05/20/26 | 7.78 on 05/06/26 | ||
| High | 53.24 on 07/15/26 | 20.79 on 07/09/26 | 11.22 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +111.20% since 01/15/26 | +155.70% since 01/15/26 | +31.24% since 01/15/26 | ||
| Low | 24.82 on 01/16/26 | 7.01 on 01/20/26 | 6.23 on 02/05/26 | ||
| High | 53.24 on 07/15/26 | 20.79 on 07/09/26 | 11.22 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,150,615 | 3,655,461 | 2,475,548 | ||
| Shares Outstanding, K | 60,905 | 191,586 | 254,163 | ||
| Annual Sales | 0 | 15,360,000 | 874,840,000 | ||
| Annual Net Income | -103,690,000 | -276,480,000 | 263,860,000 | ||
| Last Quarter Sales | 0 | 3,000,000 | 156,410,000 | ||
| Last Quarter Net Income | -23,630,000 | -73,290,000 | -721,810,000 | ||
| 60-Month Beta | 0.24 | 1.67 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 05/07/26 | -0.41 on 05/05/26 | -0.03 on 05/06/26 | ||
| Earnings Date | 08/12/26 | 08/06/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 7.62 | ||